Death receptor 3

{{Short description|Protein found in humans}}

{{cs1 config|name-list-style=vanc}}

{{Infobox_gene}}

Death receptor 3 (DR3), also known as tumor necrosis factor receptor superfamily member 25 (TNFRSF25), is a cell surface receptor of the tumor necrosis factor receptor superfamily which mediates apoptotic signalling and differentiation.{{cite journal | vauthors = Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schröter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J | title = TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95) | journal = Immunity | volume = 6 | issue = 1 | pages = 79–88 | date = Jan 1997 | pmid = 9052839 | doi = 10.1016/S1074-7613(00)80244-7 | doi-access = free }}{{cite journal | vauthors = Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, Grinham CJ, Brown R, Farrow SN | title = A death-domain-containing receptor that mediates apoptosis | journal = Nature | volume = 384 | issue = 6607 | pages = 372–5 | date = Nov 1996 | pmid = 8934525 | doi = 10.1038/384372a0 | bibcode = 1996Natur.384..372K | s2cid = 4283742 }}{{cite web | title = Entrez Gene: TNFRSF25 tumor necrosis factor receptor superfamily, member 25| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8718}} Its only known TNFSF ligand is TNF-like protein 1A (TL1A).{{cite journal | vauthors = Wang EC | title = On death receptor 3 and its ligands… | journal = Immunology | volume = 137 | issue = 1 | pages = 114–6 | date = Sep 2012 | pmid = 22612445 | pmc = 3449252 | doi = 10.1111/j.1365-2567.2012.03606.x }}

Function

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed preferentially by activated and antigen-experienced T lymphocytes. TNFRSF25 is also highly expressed by FoxP3 positive regulatory T lymphocytes. TNFRSF25 is activated by a monogamous ligand, known as TL1A (TNFSF15), which is rapidly upregulated in antigen presenting cells and some endothelial cells following Toll-Like Receptor or Fc receptor activation. This receptor has been shown to signal both through the TRADD adaptor molecule to stimulate NF-kappa B activity or through the FADD adaptor molecule to stimulate caspase activation and regulate cell apoptosis.

Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported, most of which are potentially secreted molecules. The alternative splicing of this gene in B and T cells encounters a programmed change upon T-cell activation, which predominantly produces full-length, membrane bound isoforms, and is thought to be involved in controlling lymphocyte proliferation induced by T-cell activation. Specifically, activation of TNFRSF25 is dependent upon previous engagement of the T cell receptor. Following binding to TL1A, TNFRSF25 signaling increases the sensitivity of T cells to endogenous IL-2 via the IL-2 receptor and enhances T cell proliferation. Because the activation of the receptor is T cell receptor dependent, the activity of TNFRSF25 in vivo is specific to those T cells that are encountering cognate antigen. At rest, and for individuals without underlying autoimmunity, the majority of T cells that regularly encounter cognate antigen are FoxP3+ regulatory T cells. Stimulation of TNFRSF25, in the absence of any other exogenous signals, stimulates profound and highly specific proliferation of FoxP3+ regulatory T cells from their 8-10% of all CD4+ T cells to 35-40% of all CD4+ T cells within 5 days.{{cite journal | vauthors = Schreiber TH, Wolf D, Tsai MS, Chirinos J, Deyev VV, Gonzalez L, Malek TR, Levy RB, Podack ER | title = Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation | journal = The Journal of Clinical Investigation | volume = 120 | issue = 10 | pages = 3629–40 | date = Oct 2010 | pmid = 20890040 | pmc = 2947231 | doi = 10.1172/JCI42933 | url = }}

Therapeutics

Therapeutic agonists of TNFRSF25 can be used to stimulate Treg expansion, which can reduce inflammation in experimental models of asthma, allogeneic solid organ transplantation and ocular keratitis.{{cite journal | vauthors = J Reddy PB, Schreiber TH, Rajasagi NK, Suryawanshi A, Mulik S, Veiga-Parga T, Niki T, Hirashima M, Podack ER, Rouse BT | title = TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions | journal = Journal of Virology | volume = 86 | issue = 19 | pages = 10606–20 | date = Oct 2012 | pmid = 22811539 | doi = 10.1128/JVI.01391-12 | url= | pmc = 3457251 }}{{cite journal | vauthors = Wolf D, Schreiber TH, Tryphonopoulos P, Li S, Tzakis AG, Ruiz P, Podack ER | title = Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival | journal = Transplantation | volume = 94 | issue = 6 | pages = 569–74 | date = Sep 2012 | pmid = 22902792 | doi = 10.1097/TP.0b013e318264d3ef | s2cid = 19548386 | doi-access = free }} Similarly, because TNFRSF25 activation is antigen dependent, costimulation of TNFRSF25 together with an autoantigen or with a vaccine antigen can lead to exacerbation of immunopathology or enhanced vaccine-stimulated immunity, respectively.{{cite journal | vauthors = Schreiber TH, Wolf D, Bodero M, Gonzalez L, Podack ER | title = T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination | journal = Journal of Immunology | volume = 189 | issue = 7 | pages = 3311–8 | date = Oct 2012 | pmid = 22956587 | doi = 10.4049/jimmunol.1200597 | pmc = 3449097 }} TNFRSF25 stimulation is therefore highly specific to T cell mediated immunity, which can be used to enhance or dampen inflammation depending on the temporal context and quality of foreign vs self antigen availability. Stimulation of TNFRSF25 in humans may lead to similar, but more controllable, effects as coinhibitory receptor blockade targeting molecules such as CTLA-4 and PD-1.{{cite web | title = Entrez Gene: TNFRSF25 tumor necrosis factor receptor superfamily, member 25| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8718}}

References

{{reflist|2}}

Further reading

{{refbegin | 2}}

  • {{cite journal | vauthors = Metheny-Barlow LJ, Li LY | title = Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis | journal = Seminars in Ophthalmology | volume = 21 | issue = 1 | pages = 49–58 | year = 2006 | pmid = 16517446 | doi = 10.1080/08820530500511446 | s2cid = 41728328 }}
  • {{cite journal | vauthors = Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM | title = Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 | journal = Science | volume = 274 | issue = 5289 | pages = 990–2 | date = Nov 1996 | pmid = 8875942 | doi = 10.1126/science.274.5289.990 | bibcode = 1996Sci...274..990C | s2cid = 2348299 }}
  • {{cite journal | vauthors = Bonaldo MF, Lennon G, Soares MB | title = Normalization and subtraction: two approaches to facilitate gene discovery | journal = Genome Research | volume = 6 | issue = 9 | pages = 791–806 | date = Sep 1996 | pmid = 8889548 | doi = 10.1101/gr.6.9.791 | doi-access = free }}
  • {{cite journal | vauthors = Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A | title = Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B | journal = Current Biology | volume = 6 | issue = 12 | pages = 1669–76 | date = Dec 1996 | pmid = 8994832 | doi = 10.1016/S0960-9822(02)70791-4 | s2cid = 16088373 | doi-access = free | bibcode = 1996CBio....6.1669M }}
  • {{cite journal | vauthors = Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI | title = LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 94 | issue = 9 | pages = 4615–9 | date = Apr 1997 | pmid = 9114039 | pmc = 20772 | doi = 10.1073/pnas.94.9.4615 | bibcode = 1997PNAS...94.4615S | doi-access = free }}
  • {{cite journal | vauthors = Warzocha K, Ribeiro P, Charlot C, Renard N, Coiffier B, Salles G | title = A new death receptor 3 isoform: expression in human lymphoid cell lines and non-Hodgkin's lymphomas | journal = Biochemical and Biophysical Research Communications | volume = 242 | issue = 2 | pages = 376–9 | date = Jan 1998 | pmid = 9446802 | doi = 10.1006/bbrc.1997.7948 }}
  • {{cite journal | vauthors = Grenet J, Valentine V, Kitson J, Li H, Farrow SN, Kidd VJ | title = Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma | journal = Genomics | volume = 49 | issue = 3 | pages = 385–93 | date = May 1998 | pmid = 9615223 | doi = 10.1006/geno.1998.5300 }}
  • {{cite journal | vauthors = Jiang Y, Woronicz JD, Liu W, Goeddel DV | title = Prevention of constitutive TNF receptor 1 signaling by silencer of death domains | journal = Science | volume = 283 | issue = 5401 | pages = 543–6 | date = Jan 1999 | pmid = 9915703 | doi = 10.1126/science.283.5401.543 | bibcode = 1999Sci...283..543J }}
  • {{cite journal | vauthors = Kaptein A, Jansen M, Dilaver G, Kitson J, Dash L, Wang E, Owen MJ, Bodmer JL, Tschopp J, Farrow SN | title = Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3) | journal = FEBS Letters | volume = 485 | issue = 2–3 | pages = 135–41 | date = Nov 2000 | pmid = 11094155 | doi = 10.1016/S0014-5793(00)02219-5 | doi-access = free }}
  • {{cite journal | vauthors = Frankel SK, Van Linden AA, Riches DW | title = Heterogeneity in the phosphorylation of human death receptors by p42(mapk/erk2) | journal = Biochemical and Biophysical Research Communications | volume = 288 | issue = 2 | pages = 313–20 | date = Oct 2001 | pmid = 11606045 | doi = 10.1006/bbrc.2001.5761 }}
  • {{cite journal | vauthors = Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ullrich S, Kanakaraj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P | title = TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator | journal = Immunity | volume = 16 | issue = 3 | pages = 479–92 | date = Mar 2002 | pmid = 11911831 | doi = 10.1016/S1074-7613(02)00283-2 | doi-access = free }}
  • {{cite journal | vauthors = Al-Lamki RS, Wang J, Thiru S, Pritchard NR, Bradley JA, Pober JS, Bradley JR | title = Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants | journal = The American Journal of Pathology | volume = 163 | issue = 2 | pages = 401–11 | date = Aug 2003 | pmid = 12875962 | pmc = 1868232 | doi = 10.1016/S0002-9440(10)63670-X }}
  • {{cite journal | vauthors = Wen L, Zhuang L, Luo X, Wei P | title = TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells | journal = The Journal of Biological Chemistry | volume = 278 | issue = 40 | pages = 39251–8 | date = Oct 2003 | pmid = 12882979 | doi = 10.1074/jbc.M305833200 | doi-access = free }}
  • {{cite journal | vauthors = Hillman RT, Green RE, Brenner SE | title = An unappreciated role for RNA surveillance | journal = Genome Biology | volume = 5 | issue = 2 | pages = R8 | year = 2005 | pmid = 14759258 | pmc = 395752 | doi = 10.1186/gb-2004-5-2-r8 | doi-access = free }}
  • {{cite journal | vauthors = Osawa K, Takami N, Shiozawa K, Hashiramoto A, Shiozawa S | title = Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis | journal = Genes and Immunity | volume = 5 | issue = 6 | pages = 439–43 | date = Sep 2004 | pmid = 15241467 | doi = 10.1038/sj.gene.6364097 | s2cid = 7357230 | doi-access = }}

{{refend}}

{{NLM content}}

{{Tumor necrosis factor receptor superfamily}}

{{Cytokine receptor modulators}}

Category:TNF receptor family